Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Share News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,395.00
Bid: 2,370.00
Ask: 2,420.00
Change: 15.00 (0.63%)
Spread: 50.00 (2.11%)
Open: 2,395.00
High: 2,395.00
Low: 2,395.00
Prev. Close: 2,380.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Craneware reveals deal with US hospital group

Tue, 02nd Feb 2016 11:47

(ShareCast News) - Craneware was celebrating a new contract win on Tuesday, having effectively signed up more than 50 US hospitals to its healthcare revenue systems.The AIM-listed provider of value cycle solutions to the US healthcare market said the contract was expected to deliver $7.5m (£5.2m) revenue over the initial five year term.Craneware described the customer as a growing hospital operator and consolidator that managed in excess of 50 hospitals across multiple US states - primarily in non-urban communities.Under the terms of the contract, Craneware said it would deliver its Chargemaster Corporate Toolkit to establish and manage corporate standardisation across the group's entire portfolio of owned and managed facilities.The company's revenue recognition policy would result in the full impact of the contract being seen from FY17 onwards."We are delighted to sign a significant new customer, which is testament to our position as a trusted partner for US healthcare organisations", said Craneware CEO Keith Neilson.Additionally, the company had agreed terms for a new reseller deal with VestaCare, whose VestaPay technology would be integrated with Craneware's medical necessity and price estimation products.The integrated products would be delivered via Craneware's mobile patient engagement platform which was developed following the 2014 acquisition of Kestros."The new reseller agreement deepens our reach within the early stages of patient engagement, and demonstrates our leadership in the evolving market of value-based care and patient responsibility", Neilson said."Both of these agreements not only provide Craneware with significant future revenue opportunities, but also further enhance the company's strategic value to customers", he concluded.(Sharecast News)
More News

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.